Gut Microbiome Test Results: Why One Sample Got Six Answers

A gut microbiome test counts which bacteria are present, not what they are doing. It scores you against a group it never names. One stool sample sent to six companies came back with clashing verdicts. Breath gas reads gut fermentation more directly. Fecal calprotectin rules out gut inflammation at low cost.

In 2024 a European expert group did what no buyer can do. It took one stool sample and sent it to six commercial microbiome companies. Three rated the bacterial diversity excellent or good. One judged it unfavorable, and two said average. One genus came back at 14.16% and was flagged high at one lab. At another lab it came back at 8.41% and was flagged low. The stool never changed. Only the test did.

Did you buy a gut microbiome test hoping for a map of your metabolic health? Then start with that result. Dr. Gurpreet Singh Padda, MD, MBA, MHP, and Ami Michelle Grimes wrote The Angry Gut. They lay out the problem on camera in Your Gut Bacteria Breathe Out Through Your Mouth. The deeper layer is below. A head count cannot describe activity. The reference libraries have gaps. Some gut markers have real numbers. And measuring has a place in repairing the terrain.

What is a gut microbiome test comparing you against?

No company in that test shared the reference group behind its labels. High, low, favorable and unfavorable all compared you to a group kept off the report. So no score could ever be proven wrong. Two of the six were sold through medical lab websites with no prescription needed. A clinical-looking envelope said nothing about whether the test was proven.

The panel judged the reports’ readings premature and of limited clinical use. It proposed splitting curiosity kits from regulated diagnostic kits. Know who sat on that panel. It had 21 experts from 8 countries. Of them, 38% were academic researchers, 19% came from pharma and biotechnology, and 9% came from the food industry. These were not regulators, and it was not a room without interests.

A deeper flaw sits under every reference group. The fullest catalog of gut genomes found a large store of extra genes. Many belong only to certain human populations. So a score built on someone else’s group may compare you to a different gene pool. It may not compare you to a healthier person at all. A metabolic audit starts from markers that can be checked.

Does a gut microbiome test show what your bacteria are doing?

For years I read species lists as if they were diagnoses. I treated names on a page when the page was only a head count. Testing the same stool for both DNA and RNA shows why that fails. DNA shows what genes the bugs carry. RNA shows which genes they are using. In a group of adult men, only 44% of the common pathways were being used, 81 of 182. At the gene-family level the gap grew wider. The DNA held 1,569,171 families. The RNA held 602,896.

In only about one third of pathways, the same microbes led in both the RNA and the DNA. In the other two thirds, the bug carrying a gene was not the one using it. So a report can name the wrong bug for a job.

The reference library is thin as well. More than 70% of gut species in the fullest catalog have never been grown in a lab. And 40% of the protein catalog has no known function. Fermentation output, not a species name, is what feeds the colon lining.

Why do gut microbiome test results change from sample to sample?

Researchers studied fifty-three healthy Belgian women. Stool form tracked every major microbiome marker. Looser stool ran with fewer species. Methanobrevibacter and Akkermansia levels moved with stool form. Faster transit seemed to favor fast-growing bugs that outrun the washout. That pattern was absent in people with a Prevotella gut type.

So part of a diversity score measures how fast that sample moved through the colon that day. Two samples taken on days with different stool form do not measure the same thing. A change between them is not proof of repair or decline. Meal frequency is its own lever on the terrain.

RNA sits closer to activity, and moves more

If DNA shows capacity and RNA shows activity, why not just test RNA? Because activity moves. In one person, DNA profiles change less over time than they differ between people. RNA profiles changed about as much within one person as between people. Shifts in the DNA itself explained roughly 74% of that. One sample tells you lasting facts about who is there. It does not tell you what they are doing.

Most pathways that ran high or low kept the same direction at each time point. Still, no RNA microbiome test has been proven in advance to guide treatment. Part of the reason is design. A clean test group leaves out metabolic disease, many medications and anxiety. That removes most of the people who need the answer. Metabolic terrain explains why identical treatments diverge.

How accurate is a breath test for gut bacteria?

In the RNA data, only Methanobrevibacter carried and used the genes for making methane. Those genes were some of the most active in the group, yet rare in the DNA. A rare gene worked hard by one bug gets averaged away in a stool report. It shows up plainly in the gas you breathe out.

Breath testing has accuracy problems of its own. Researchers tested 139 patients with unexplained gas, bloating and diarrhea. Each had a culture from the small bowel and a glucose breath test within one week. The two agreed 65.5% of the time. The breath test caught only 42% of the cases the culture found. Change the method and the disease rate moves. One center switched to the consensus method. Positive results rose from 29.7% to 39.5%, and the new positives came through methane rules. Cravings answer to the same fermentation output.

Where measurement meets metabolism

Methane reaches beyond the bowel. One study treated eleven prediabetic adults with obesity who tested methane positive. They took 10 days of neomycin plus rifaximin. Breath methane cleared in eight. In those eight, LDL, total cholesterol and late insulin in a glucose tolerance test improved. Energy harvest did not change. So the idea that methane bugs make you heavier by pulling extra calories from food did not hold. Stool methane-bug counts did not fall by a significant amount. There was no control group and no blinding. It is a hypothesis with a pulse, not a result. Any antibiotic decision belongs with your physician.

The markers with real numbers are the plain ones. Fecal calprotectin separates inflammatory from functional bowel disease. It has 85.8% sensitivity and 91.7% specificity. But suppose 1% of people tested have inflammatory bowel disease. Then a negative result is right 99.8% of the time, and a positive result only 9%. It rules out very well and confirms poorly. A cutoff at or below 50 µg/g caught more cases than a higher cutoff, 87% against 79%. Fecal elastase-1 at 200 µg/g screens for a weak pancreas that cannot make enough digestive enzymes. It runs 0.94 sensitivity and 0.69 specificity for pancreatic exocrine insufficiency. But watery stool dilutes it and can drag a result falsely low. Systemic inflammation markers follow the same rule-out logic.

The repair logic follows. Measure activity where you can. Rule out inflammation at low cost. Match each marker to one question. Head-count kits are built for repeat sales. A test that ends the testing is poor business and sound medicine. The full evidence, including the weak spots in the methane trials, sits in the Angry Gut Deep Dive on gut testing.

Frequently asked questions

Are at-home gut microbiome tests accurate?

They reliably produce a report. They do not reliably produce the same answer. In 2024 one sample went to six companies. The diversity verdicts ran from excellent to unfavorable. The same genus was labeled high at one lab and low at another. None shared its reference group. Treat a kit as curiosity, not diagnosis. Do not build a treatment plan on it. Longevity medicine should rest on measures that hold up.

What does the diversity score on my stool report mean?

Less than the colored bar suggests. Diversity moves with stool form, so a looser sample tends to read lower no matter your health. It is also blind to activity. In adult men, less than half of the common pathways were actually being used. It is a number with no shared reference and no treatment attached. The microbiome matters to joints in ways a score cannot capture.

Is RNA microbiome testing better than DNA testing?

RNA sits closer to what the bugs are actually doing. Far fewer gene families show up in RNA than in DNA. But RNA profiles swing within one person over time almost as much as they differ between people. So one sample is a snapshot, not a baseline. Repeat tests help. No RNA test has yet been proven to guide treatment. When treatment still fails, the next suspect may be the environment.

Can methane on a breath test affect blood sugar?

Possibly. A small study had eleven prediabetic adults with obesity who tested methane positive. All of them got antibiotics. In those whose breath methane cleared, cholesterol and insulin during a glucose tolerance test improved. There was no control group, and energy harvest from food did not change. It is a lead worth measuring in the right patient. It is not a reason to take antibiotics. Continuous glucose data adds context between lab draws.

Which gut tests actually have good evidence?

Fecal calprotectin is the strongest rule-out for inflammatory bowel disease. When few people tested have the disease, a negative result is right 99.8% of the time. Fecal elastase-1 screens for a weak pancreas but reads falsely low in watery stool. A breath test on the consensus method measures hydrogen, methane and carbon dioxide. It reads fermentation activity. None of them is a microbiome score, and each answers one question. A clean result is not always the end of the story.

Are gut microbiome tests worth it?

Not as a guide to treatment. An expert panel judged the report readings premature and of limited clinical use. It proposed splitting curiosity kits from regulated diagnostic tests. A head-count kit is built for repeat sales. The useful tests each answer one question, such as whether inflammation is present. A good test ends the testing instead of starting a subscription.

What are the different types of gut microbiome tests?

A standard kit reads bacterial DNA. That shows who is present and what genes they carry. An RNA test reads which genes are switched on. That is closer to activity but changes more over time. A breath test measures the gases bacteria make, so it reads fermentation directly. Fecal calprotectin and fecal elastase-1 are not microbiome scores. Each answers a single clinical question.

Sources

1. Rodriguez, J., Cordaillat-Simmons, M., Badalato, N., Berger, B., Breton, H., de Lahondès, R., Deschasaux-Tanguy, M., Desvignes, C., D’Humières, C., Kampshoff, S., Lavelle, A., Metwaly, A., Quijada, N. M., Seegers, J. F. M. L., Udocor, A., Zwart, H., Maguin, E., Doré, J., & Druart, C. (2024). Microbiome testing in Europe: Navigating analytical, ethical and regulatory challenges. Microbiome, 12(1), 258. https://doi.org/10.1186/s40168-024-01991-x
2. Abu-Ali, G. S., Mehta, R. S., Lloyd-Price, J., Mallick, H., Branck, T., Ivey, K. L., Drew, D. A., DuLong, C., Rimm, E., Izard, J., Chan, A. T., & Huttenhower, C. (2018). Metatranscriptome of human faecal microbial communities in a cohort of adult men. Nature Microbiology, 3(3), 356-366. https://doi.org/10.1038/s41564-017-0084-4
3. Almeida, A., Nayfach, S., Boland, M., Strozzi, F., Beracochea, M., Shi, Z. J., Pollard, K. S., Sakharova, E., Parks, D. H., Hugenholtz, P., Segata, N., Kyrpides, N. C., & Finn, R. D. (2021). A unified catalog of 204,938 reference genomes from the human gut microbiome. Nature Biotechnology, 39(1), 105-114. https://doi.org/10.1038/s41587-020-0603-3
4. Vandeputte, D., Falony, G., Vieira-Silva, S., Tito, R. Y., Joossens, M., & Raes, J. (2016). Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut, 65(1), 57-62. https://doi.org/10.1136/gutjnl-2015-309618
5. Mehta, R. S., Abu-Ali, G. S., Drew, D. A., Lloyd-Price, J., Subramanian, A., Lochhead, P., Joshi, A. D., Ivey, K. L., Khalili, H., Brown, G. T., DuLong, C., Song, M., Nguyen, L. H., Mallick, H., Rimm, E. B., Izard, J., Huttenhower, C., & Chan, A. T. (2018). Stability of the human faecal microbiome in a cohort of adult men. Nature Microbiology, 3(3), 347-355. https://doi.org/10.1038/s41564-017-0096-0
6. Erdogan, A., Rao, S. S. C., Gulley, D., Jacobs, C., Lee, Y. Y., & Badger, C. (2015). Small intestinal bacterial overgrowth: Duodenal aspiration vs glucose breath test. Neurogastroenterology and Motility, 27(4), 481-9. https://doi.org/10.1111/nmo.12516
7. Baker, J. R., Chey, W. D., Watts, L., Armstrong, M., Collins, K., Lee, A. A., Dupati, A., Menees, S., Saad, R. J., Harer, K., & Hasler, W. L. (2021). How the North American Consensus protocol affects the performance of glucose breath testing for bacterial overgrowth versus a traditional method. The American Journal of Gastroenterology, 116(4), 780-787. https://doi.org/10.14309/ajg.0000000000001110
8. Mathur, R., Chua, K. S., Mamelak, M., Morales, W., Barlow, G. M., Thomas, R., Stefanovski, D., Weitsman, S., Marsh, Z., Bergman, R. N., & Pimentel, M. (2016). Metabolic effects of eradicating breath methane using antibiotics in prediabetic subjects with obesity. Obesity (Silver Spring), 24(3), 576-82. https://doi.org/10.1002/oby.21385
9. Dajti, E., Frazzoni, L., Iascone, V., Secco, M., Vestito, A., Fuccio, L., Eusebi, L. H., Fusaroli, P., Rizzello, F., Calabrese, C., Gionchetti, P., Bazzoli, F., & Zagari, R. M. (2023). Systematic review with meta-analysis: Diagnostic performance of faecal calprotectin in distinguishing inflammatory bowel disease from irritable bowel syndrome in adults. Alimentary Pharmacology & Therapeutics, 58(11-12), 1120-1131. https://doi.org/10.1111/apt.17754
10. de la Iglesia, D., Agudo-Castillo, B., Galego-Fernández, M., Rama-Fernández, A., & Domínguez-Muñoz, J. E. (2025). Diagnostic accuracy of fecal elastase-1 test for pancreatic exocrine insufficiency: A systematic review and meta-analysis. United European Gastroenterology Journal, 13(8), 1571-1582. https://doi.org/10.1002/ueg2.70061

Medically reviewed by Dr. Gurpreet Singh Padda, MD, MBA, MHP, board certified in anesthesiology, pain medicine, interventional pain management, addiction medicine and obesity medicine. Adapted from Chapter 25 of The Angry Gut by Dr. Padda and Ami Michelle Grimes. Last reviewed September 2026.